Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AURO-LIOTHYRONINE DIN 02549999

Status: Marketed
Holder: AURO PHARMA INC
Molecule: LIOTHYRONINE (LIOTHYRONINE SODIUM)

Health Canada record

Active ingredient(s)LIOTHYRONINE (LIOTHYRONINE SODIUM) 5 MCG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCH03AA02 LIOTHYRONINE SODIUM
Original market date18-Sep-2025
Current status date18-Sep-2025
SourceHealth Canada DPD

Establishment licence of the holder

Auro Pharma Inc — licence 101305, currently licensed, last inspection rating C (2023-09-27).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing LIOTHYRONINE (LIOTHYRONINE SODIUM)

DINProductCompanyFormStrengthStatus
02550008AURO-LIOTHYRONINEAURO PHARMA INCTabletLIOTHYRONINE (LIOTHYRONINE SODIUM) 25 MCGMarketed
01919458CYTOMELPFIZER CANADA ULCTabletLIOTHYRONINE (LIOTHYRONINE SODIUM) 5 MCGMarketed
01919466CYTOMELPFIZER CANADA ULCTabletLIOTHYRONINE (LIOTHYRONINE SODIUM) 25 MCGMarketed
02494345TEVA-LIOTHYRONINETEVA CANADA LIMITEDTabletLIOTHYRONINE (LIOTHYRONINE SODIUM) 25 MCGMarketed
02494337TEVA-LIOTHYRONINETEVA CANADA LIMITEDTabletLIOTHYRONINE (LIOTHYRONINE SODIUM) 5 MCGMarketed
02561298ZDS-LIOTHYRONINEZYDUS LIFESCIENCES LIMITEDTabletLIOTHYRONINE (LIOTHYRONINE SODIUM) 5 MCGMarketed
02561301ZDS-LIOTHYRONINEZYDUS LIFESCIENCES LIMITEDTabletLIOTHYRONINE (LIOTHYRONINE SODIUM) 25 MCGMarketed

Notices of Compliance

NOCDateSubmissionReason
336582024-07-17Abbreviated New Drug Submission (ANDS)
Request a quote for AURO-LIOTHYRONINE

How to read a Canadian DIN record